The economic burden of major adult visual disorders in the United States.
about
Mutations in SCO2 are associated with autosomal-dominant high-grade myopiaNutritional supplements for age-related macular degenerationCommon MFRP sequence variants are not associated with moderate to high hyperopia, isolated microphthalmia, and high myopiaIndividualized Treatment of Neovascular Age-Related Macular Degeneration: What are Patients Gaining? Or Losing?Aging, diabetes, and the public health system in the United StatesMedical Management of Glaucoma in the 21st Century from a Canadian PerspectiveAssociation of Socioeconomic Position With Sensory Impairment Among US Working-Aged AdultsThe worldwide epidemic of diabetic retinopathy.Use of electronic health records and administrative data for public health surveillance of eye health and vision-related conditions in the United States.[Calculation of disease-related costs in claims data analyses with the example of attention-deficit hyperactivity disorder. Comparison of methods].Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States.Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular DegenerationA low-vision rehabilitation program for patients with mild cognitive deficitsResource use and costs associated with diabetic macular edema in elderly persons.Present and possible therapies for age-related macular degeneration.Are you compliant with addressing glaucoma adherence?Image-guided evaluation and monitoring of treatment response in patients with dry eye disease.Age-related eye diseases and visual impairment among U.S. adultsNew ZNF644 mutations identified in patients with high myopiaFundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseasesDisparity in prevalence of self-reported visual impairment in older adults among U.S. race-ethnic subgroups.Ocular lubricant use in medically and surgically treated glaucoma: a retrospective longitudinal analysis.Cone structure in subjects with known genetic relative risk for AMD.A genome-wide association study for myopia and refractive error identifies a susceptibility locus at 15q25.Developments in Ocular Genetics: 2013 Annual ReviewGene profiling in experimental models of eye growth: clues to myopia pathogenesisTopical nutraceutical Optixcare EH ameliorates experimental ocular oxidative stress in rats.The effects of technological advances on outcomes for elderly persons with exudative age-related macular degeneration.The lifetime economic burden of keratoconus: a decision analysis using a markov model.Cost-effectiveness analysis of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.Health literacy issues among women with visual impairments.Review of therapeutic advances in diabetic retinopathy.Time trend of prevalence of self-reported cataract and its association with prolonged sitting in Taiwan from 2001 and 2013.Diabetic Retinopathy-Update on Prevention Techniques, Present Therapies, and New Leads.Racial variations in the prevalence of refractive errors in the United States: the multi-ethnic study of atherosclerosis.Defined culture of human embryonic stem cells and xeno-free derivation of retinal pigmented epithelial cells on a novel, synthetic substrate.Using Markov Chains to predict the natural progression of diabetic retinopathySmoking and visual impairment among older adults with age-related eye diseases.Socioeconomics of long-term glaucoma therapy in IndiaThe cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy.
P2860
Q24339538-87080F46-E13F-418E-956A-9BD443046164Q24603642-4192959C-43A9-4C9B-8F6E-CF9AF73B5FE1Q24651845-670DCCF5-5BF4-4493-8B04-B863D4DDF6BFQ26799492-F9EEE2D1-4ACD-4584-8CE8-B17DE32C85E7Q26852929-2D350374-6709-4B1F-A168-0EAE225AA1D9Q28074316-1B917E73-2891-498F-A0AA-256EA489331DQ28394047-DE415ED7-5C61-4B51-9227-6E1B6B167AECQ30394609-41B03D1E-9D22-4531-9EB5-9099ABA97695Q30577698-9FCCCB03-D7E2-45D9-AA77-DDA9DE8A462FQ30596477-4520FD95-2483-4DB9-8BC0-FB611ACD858CQ30917738-A5F62A19-D6E5-45C7-9C9B-4C4E3D1F7D84Q31015035-4014E6BE-47DA-401C-8C15-078C8671975DQ33355743-AFBC08B7-B6E7-47A4-827E-998CA2E5DFEAQ33390920-62C35A48-571A-472C-8539-3BFB187B40C0Q33562731-69BED839-3617-4AA7-8FFD-F87D4816FDB2Q33617722-7249E5F0-9130-4B62-8A71-02F70AEC8DCEQ33686417-0A97C989-5D98-4FA4-8DA8-A806D377BFEEQ33810512-74543EC1-1069-4315-BDE4-8CD6EA235BB1Q33830286-876E7951-7C08-4F38-AC6A-E660D27E7A3AQ33840787-B55552D2-9CB1-4A42-9FD0-0ABEAB34128BQ33855212-F72FBAAD-E3F0-4469-88F0-1BFCE5B2D7CFQ33865232-6F8D2155-B0EF-4EB4-8AF0-CFEDBE4D65C9Q33953252-8EA37143-E83D-4984-9BB9-D36D54B4E75CQ33969884-A4B522D2-12E9-4085-B360-3511B0009AE3Q33991982-C542F8B3-A8D9-4AE3-9A90-272F3CB2AC78Q34104333-00D7A877-F4F6-474E-9FC7-6BBBDCA69904Q34116939-7692AED3-3A1C-4EC5-B2FC-FC263A89FD0DQ34158108-B87B2EE6-A399-48C8-9829-12ECB02CB4B7Q34163774-2A5E57BA-BDC4-47C5-964F-95F55857FA2BQ34232330-88894D54-62A8-4FD6-8183-A1E4C1C8A12EQ34361035-A312D029-D514-4BFE-8677-44CFF100E010Q34475449-2D00A9A6-E5FA-45CE-A44C-31E8CE0B87B8Q34515087-23F4AABD-B879-4BEE-87CD-1CCFB0CBED7EQ34553087-B727E99C-ED44-4E32-8873-5F39FC1E7B04Q34604903-06BA8EB7-5A77-4448-8AFB-2CEEAFD71D0BQ35001372-E3C88631-8B91-4111-A91B-656DCC97BCFCQ35075399-18CF75A9-9F75-4984-9092-43AE236A4D6FQ35107186-9C2EE8D3-54AF-49B1-B99A-6BB74BCE7BA8Q35189172-13535ABB-D0A9-464E-9B22-338A19ACE71BQ35194580-3A4559C7-321D-40B9-83BF-2900BDAE276B
P2860
The economic burden of major adult visual disorders in the United States.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The economic burden of major adult visual disorders in the United States.
@en
type
label
The economic burden of major adult visual disorders in the United States.
@en
prefLabel
The economic burden of major adult visual disorders in the United States.
@en
P2093
P50
P1433
P1476
The economic burden of major adult visual disorders in the United States.
@en
P2093
David B Rein
Jinan Saaddine
Nancy McCall
Ping Zhang
Ronald Klein
Sandeep Vijan
Thomas J Hoerger
P304
P356
10.1001/ARCHOPHT.124.12.1754
P407
P577
2006-12-01T00:00:00Z